Robert Eugene Kristal is Chief Financial Officer of BioRestorative Therapies, Inc.. Currently has a direct ownership of 7,994 shares of BRTX, which is worth approximately $12,470. The most recent transaction as insider was on Jun 15, 2022, when has been sold 194 shares (Common Stock) at a price of $3.61 per share, resulting in proceeds of $700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.99K
0% 3M change
0% 12M change
Total Value Held $12,470

Robert Eugene Kristal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2022
BUY
Open market or private purchase
$700 $3.61 p/Share
194 Added 2.37%
7,994 Common Stock
Jun 07 2022
BUY
Open market or private purchase
$912 $4.56 p/Share
200 Added 2.5%
7,800 Common Stock
Apr 08 2022
BUY
Open market or private purchase
$43,396 $5.71 p/Share
7,600 Added 50.0%
7,600 Common Stock
REK

Robert Eugene Kristal

Chief Financial Officer
Melville, NY

Track Institutional and Insider Activities on BRTX

Follow BioRestorative Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BRTX shares.

Notify only if

Insider Trading

Get notified when an Bio Restorative Therapies, Inc. insider buys or sells BRTX shares.

Notify only if

News

Receive news related to BioRestorative Therapies, Inc.

Track Activities on BRTX